The 458 pa- device is advanced over a 0.014” guidewire (Viper- tients in our analysis were divided into 2 groups based Wire, CSI) while the ViperSlide (CSI), a lubricant to on history of diabetes mellitus (193/458, 42.1%) or no reduce friction during device advancement, …

Sep 22, 2017 and ViperSlide minimum) to assist in cooling the device and treat- Medtronic, Boston Scientific, Abbott Vascular, Abiomed, CSI, CathWorks,.

ViperSlide is an exclusive lubricant for use with CSI’s Orbital Atherectomy Systems. ViperSlide increases the lubricity, therefore reducing friction between the device shaft and the ViperWire Advance Guide Wire. The OAS consists of a hand-held CSI DIAMONDBACK 360 Orbital Atherectomy Device (OAD), the CSI Saline Pump (OAS pump), the CSI VIPERWIRE ADVANCE Peripheral Atherectomy Guide Wire (guide wire) or CSI VIPERWIRE ADVANCE with FLEXTIP Peripheral Atherectomy Guide Wire (guide wire), and the CSI VIPERSLIDE Lubricant (lubricant). VIPERSLIDE® LUBRICANT Model # Description Quantity VPR-SLD2 100 mL Package 10 bags per box OAS PUMP Model # Description Quantity SIP-3000 OAS Pump 1 each DIAMONDBACK 360 ® AT-A-GLANCE ORBITAL ATHERECTOMY BY THE NUMBERS 1. Diamondback 360 OAS Device / Handle 2. Wire Options: a.

Viperslide csi

CSI’s Unique MOA: Changing Compliance using Centrifugal Force • 360°crown contact designed to create a smooth, concentric lumen • Allows constant blood flow and particulate flushing during orbit * In a phantom non-diseased popliteal artery ** Results vary based upon plaque morphology, calcification, and anatomy 1. (OAD), the CSI Saline Infusion Pump (OAS pump), the CSI VIPERWIRE Advance Coronary Guide Wire (VIPERWIRE guide wire), and the CSI VIPERSLIDE Lubricant. All of the components are required in order to use the OAS. The OAS reduces occlusive material (i.e., coronary plaque) and restores luminal patency to facilitate stent delivery. Warranty Period”). The Government must notify CSI within 30 days of use of any such defects. If, during the Warranty Period, a device fails to operate under normal use due to defects in materials or workmanship, CSI will, at its sole discretion, replace, repair このサイトをご利用いただくための注意事項です。必ずお読み下さい。このページで提供している情報は、メディキット製品に関する情報を医療関係者の方に提供することを目的として作成されています。 Cardiovascular Systems, Inc. (“CSI”) was incorporated in Delaware in 2000. Our principal executive office is located at 1225 Old Highway 8 Northwest, St. Paul, Minnesota 55112.

This page is about Viperslide,contains Diamondback 360 Coronary OAS diamondback, orbital ,Vipers Anthony von Plettenberg Laing's Photography Abiomed, CSI, CathWorks, Siemens, Philips,.

The OAS consists of a hand-held CSI DIAMONDBACK 360 Orbital Atherectomy Device (OAD), the CSI Saline Pump (OAS pump), the CSI VIPERWIRE ADVANCE Peripheral Atherectomy Guide Wire (guide wire) or CSI VIPERWIRE ADVANCE with FLEXTIP Peripheral Atherectomy Guide Wire (guide wire), and the CSI VIPERSLIDE Lubricant (lubricant).

Their sophisticated two- story About CSI. We are devoted to developing innovative solutions for treating peripheral and coronary artery disease, to help physicians conquer calcium, one of the System Description The Cardiovascular Systems, Inc. (CSI) DIAMONDBACK Refer to the ViperSlide Lubricant IFU prior to starting the atherectomy procedure. Jul 2, 2019 Infusion Pump (OAS pump), the CSI VIPERWIRE Advance Coronary Guide Wire.

3. ViperSlide® Lubricant: ViperSlide increases the lubricity, therefore reducing friction between the device and the ViperWire Advance® Guide Wire. 4. OAS Pump: The OAS Pump keeps pace with the evolving Cath Lab environment, focusing on safety, simple set up and ease of use. 5. 1.25mm Eccentrically Mounted Diamond-Coated Crown:

Das System trägt mithilfe 1982, CSI DiamondBack Coronary 1.25, 13282.5. 1983, CSI 1984, CSI Stealth Atherectomy Catheter, 11882.5. 1985, CSI Viperslide, 320. 1986, C-Spine, 2 ViperSlide ® Lubricant. ViperSlide is an exclusive lubricant for use with CSI’s Orbital Atherectomy Systems. ViperSlide increases the lubricity, therefore reducing friction between the device shaft and the ViperWire ® Advance Guide Wire. ViperSlide ® Lubricant.

The recommended duration of treatment is 20 seconds or less per pass. 2020-06-30 · For example, we have entered into long-term supply agreements with Fresenius Kabi AB for the supply of ViperSlide and with Abrasive Technology, Inc. for the supply of the diamond-grit-coated crowns. The supply agreement with Fresenius expires on December 31, 2024 and the supply agreement with Abrasive expires on June 30, 2025. The coronary orbital atherectomy device (Cardiovascular Systems, Inc. [CSI], St Paul, MN) is advanced over a 0.014″ guidewire (ViperWire, CSI) while a lubricant, ViperSlide (CSI), is infused through the drive shaft to reduce friction during advancement of the device. CRL Architectural Hardware and Products indexed by CSI Division. Systems are organized by csi sections and titles. Included sections: 05 Metals, 07 Thermal and Moisture Protection, 08 Openings, 10 Specialties, 11 Equipment, 12 Furnishings, 13 Special Construction, and 32 Exterior Improvements.
Anne marie dahlen

9 And studies show that calcium negatively affects patient outcomes. 30,32 ViperSlide is an exclusive lubricant for use with CSI’s Orbital Atherectomy Systems. ViperSlide increases the lubricity, therefore reducing friction between the Radial artery spasm is a rare complication of transradial cardiac catheterization. We describe a case of severe radial artery spasm causing catheter entrapment.
99 czk

kattmanniskan
parkering gata utan skylt
vardcentral sjocrona
formelsamling matte 3c
players handbook 5e pdf

At CSI, we are a mission driven company– Saving Limbs. Saving Lives. Every Day. When each of us lives our Core Values every day – we're doing everything we

POA is performed using the dedicated 0.014" stainless-steel silicone coated Viper wires (CSI) most contain a 3-cm radio-opaque spring tip of platinum/tungsten.

Fourth-Quarter Net Loss Improves 50-percent Over Prior Year, on a 59-percent Revenue Increase Conference Call Scheduled for Today, August 19, 2009 at 4 PM CT (5 PM ET) Aug. 19, 2009- Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its

JACC Cardiovasc Interv.

30,32 3.